<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=1200, user-scalable=yes, initial-scale=0.4, minimum-scale=0.1">
    <title>Ephedrine - Complete Profile</title>
    <link rel="stylesheet" href="/Dyo-s-Dubious-Domain/style.css">
    <link rel="icon" type="image/svg+xml" href="/Dyo-s-Dubious-Domain/assets/logo.svg">
    <script>
        // Set base path for JavaScript files to use
        window.SITE_BASE_PATH = '/Dyo-s-Dubious-Domain/';
        
        // Force desktop behavior by overriding mobile detection
        window.isMobile = false;
        window.isDesktop = true;
        
        // Override any mobile detection functions
        if (window.matchMedia) {
            const originalMatchMedia = window.matchMedia;
            window.matchMedia = function(query) {
                // Force desktop media queries to always match for min-width
                // and mobile queries to never match
                if (query.includes('max-width') && (query.includes('768px') || query.includes('480px'))) {
                    return { matches: false, addListener: function() {}, removeListener: function() {} };
                }
                if (query.includes('min-width')) {
                    return { matches: true, addListener: function() {}, removeListener: function() {} };
                }
                return originalMatchMedia.call(this, query);
            };
        }
    </script>
</head>

<body class="
  
  
  
  ">
    <header class="page-header">
  <div class="container">
    <div class="page-header__content">
      <div class="logo-container">
        <a href="/Dyo-s-Dubious-Domain/" class="site-title">Dyo's Dubious Domain</a>
      </div>
      
      <nav>
        <ul role="list" class="nav-list flex-group">
          <li>
            <a href="/Dyo-s-Dubious-Domain/">Home</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/dyos-domain/">Dyo's Domain</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/about/">About</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/profile/">My Profile</a>
          </li>
         
        </ul>
      </nav>
    </div>
    
    <!-- Search Bar - Now underneath header -->
    <div class="search-container">
      <input type="text" id="search-input" placeholder="Search substances..." class="search-input" />
      <div id="search-results" class="search-results" style="display: none;"></div>
    </div>
  </div>
</header>

    <main>
      
<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚ÜÅE<a href="/dyos-domain/stimulants/">Stimulants</a> ‚ÜÅE<span>Ephedrine</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üåø Ephedrine</h1>
        <h2 class="chemical-name">(-)-Ephedrine</h2>
         <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="Ephedrine" 
                data-category="Stimulants" 
                data-chemical="(-)-Ephedrine">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Sources</h3>
          <div class="names-grid">
            <div class="name-category">
              <h4>Chemical Names</h4>
              <span>Ephedrine</span> ‚Ä¢ <span>(-)-Ephedrine</span> ‚Ä¢ <span>L-Ephedrine</span> ‚Ä¢ <span>Ephedrine HCl</span>
            </div>
            <div class="name-category">
              <h4>Traditional Names</h4>
              <span>Ma Huang</span> ‚Ä¢ <span>Desert Tea</span> ‚Ä¢ <span>Mormon Tea</span> ‚Ä¢ <span>Joint Fir</span>
            </div>
            <div name-category">
              <h4>Brand Names</h4>
              <span>Bronkaid</span> ‚Ä¢ <span>Primatene</span> ‚Ä¢ <span>Ephedrine Sulfate</span> ‚Ä¢ <span>Akovaz</span>
            </div>
            <div class="name-category">
              <h4>Chemical Identifiers</h4>
              <span>CAS: 299-42-3</span> ‚Ä¢ <span>Formula: C‚ÇÅÔøΩEH‚ÇÅ‚ÇÖNO</span> ‚Ä¢ <span>MW: 165.23 g/mol</span>
            </div>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category stimulant">Stimulant</span>
          <span class="legal-status controlled">Controlled/Restricted</span>
          <span class="duration medium">3-6 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/Dyo-s-Dubious-Domain/assets/substances/ephedrine.jpg" alt="Ephedra plants and ephedrine pills with warning symbols" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>üß¨ C‚ÇÅÔøΩEH‚ÇÅ‚ÇÖNO</p>
            <p>MW: 165.23 g/mol</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pure Ephedrine (HCl salt)</h4>
          <ul>
            <li><strong>Appearance:</strong> White crystalline powder or small crystals</li>
            <li><strong>Texture:</strong> Fine crystalline powder, slightly hygroscopic</li>
            <li><strong>Odor:</strong> Faint, characteristic aromatic smell</li>
            <li><strong>Taste:</strong> Bitter, numbing on tongue</li>
            <li><strong>Solubility:</strong> Freely soluble in water, soluble in alcohol</li>
            <li><strong>Melting point:</strong> 217-220¬∞C (HCl salt)</li>
          </ul>
        </div>
        
        <div class="commercial-forms">
          <h4>Commercial & Natural Forms</h4>
          <ul>
            <li><strong>Pharmaceutical tablets:</strong> 25mg tablets (Bronkaid, Primatene)</li>
            <li><strong>Injectable solutions:</strong> Medical ephedrine sulfate</li>
            <li><strong>Raw plant material:</strong> Dried Ephedra sinica stems</li>
            <li><strong>Herbal extracts:</strong> Concentrated ma huang preparations</li>
            <li><strong>Combination products:</strong> Often with guaifenesin or caffeine</li>
          </ul>
        </div>
        
        <div class="plant-sources">
          <h4>üå± Natural Plant Sources</h4>
          <p><strong>Ephedra sinica (Ma Huang):</strong> Primary source, highest ephedrine content (1-3%)</p>
          <p><strong>Ephedra intermedia:</strong> Traditional Chinese medicine source</p>
          <p><strong>Ephedra equisetina:</strong> Common commercial source</p>
          <p><strong>Ephedra nevadensis (Mormon Tea):</strong> Low ephedrine content, primarily used historically</p>
          <p><strong>Note:</strong> Different Ephedra species contain varying alkaloid profiles</p>
        </div>
        
        <div class="legal-identification">
          <h4>‚öñÔ∏ÅELegal Restrictions & Identification</h4>
          <p><strong>Purchase restrictions:</strong> ID required, quantity limits, logbook signing</p>
          <p><strong>Packaging requirements:</strong> Behind pharmacy counter, tamper-evident</p>
          <p><strong>Suspicious indicators:</strong> Large quantity purchases, frequent purchases</p>
          <p><strong>Legitimate use:</strong> Asthma treatment, nasal congestion, hypotension</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      
      <div class="medical-dosing">
        <h4>üè• Medical/Therapeutic Dosing</h4>
        <div class="dosage-chart">
          <div class="dose-range therapeutic">
            <span class="range-label">Bronchodilator</span>
            <span class="dose-amount">12.5-25mg</span>
            <div class="dose-bar"></div>
            <span class="frequency">Every 4-6 hours</span>
          </div>
          <div class="dose-range weight-loss">
            <span class="range-label">Weight Loss (historical)</span>
            <span class="dose-amount">20-25mg</span>
            <div class="dose-bar"></div>
            <span class="frequency">3x daily with caffeine</span>
          </div>
          <div class="dose-range maximum">
            <span class="range-label">Maximum Daily</span>
            <span class="dose-amount">150mg</span>
            <div class="dose-bar"></div>
            <span class="frequency">FDA limit</span>
          </div>
        </div>
      </div>
      
      <div class="recreational-warning">
        <h4>‚ö†ÔøΩEÔøΩERecreational Use Warning</h4>
        <p><strong>Not recommended for recreational use:</strong> Ephedrine has a poor recreational profile with significant cardiovascular risks and limited euphoric effects compared to other stimulants. The risk-to-benefit ratio is unfavorable for non-medical use.</p>
      </div>
      
      <div class="dosage-factors">
        <h4>Dosage Considerations</h4>
        <ul>
          <li><strong>Individual sensitivity:</strong> Varies greatly between users</li>
          <li><strong>Cardiovascular status:</strong> Lower doses for heart conditions</li>
          <li><strong>Age factors:</strong> Elderly more sensitive to effects</li>
          <li><strong>Tolerance development:</strong> Occurs with regular use</li>
          <li><strong>Combination effects:</strong> Synergistic with caffeine</li>
          <li><strong>Time of day:</strong> Avoid late dosing due to insomnia</li>
        </ul>
      </div>
      
      <div class="traditional-dosing">
        <h4>üìú Traditional Chinese Medicine Dosing</h4>
        <p><strong>Ma Huang decoction:</strong> 3-9g dried herb (equivalent to ~30-300mg ephedrine)</p>
        <p><strong>TCM principle:</strong> Always combined with other herbs, never used alone</p>
        <p><strong>Preparation method:</strong> Boiled decoction, alkaloids extracted in hot water</p>
        <p><strong>Duration:</strong> Short-term use only, typically 3-7 days maximum</p>
      </div>
      
      <p class="dosage-note"><strong>Legal Warning:</strong> Purchase and possession are heavily regulated. Large quantities may trigger DEA investigation as potential methamphetamine precursor.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline - Oral Administration</h4>
        <div class="timeline-item">
          <span class="time">T+0:15-0:45</span>
          <span class="effect">Onset - increased heart rate, alertness</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+0:45-2:00</span>
          <span class="effect">Peak - maximum cardiovascular and CNS effects</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+2:00-4:00</span>
          <span class="effect">Plateau - sustained stimulation, bronchodilation</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+4:00-6:00</span>
          <span class="effect">Comedown - gradual return to baseline</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+6:00-12:00</span>
          <span class="effect">After-effects - possible rebound fatigue</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category therapeutic">
          <h4>‚úÅETherapeutic Effects</h4>
          <ul>
            <li>Bronchodilation and improved breathing</li>
            <li>Nasal decongestant effects</li>
            <li>Increased blood pressure (treatment for hypotension)</li>
            <li>Enhanced alertness and focus</li>
            <li>Appetite suppression</li>
            <li>Mild thermogenic effects</li>
            <li>Increased energy and stamina</li>
            <li>Fat oxidation enhancement</li>
          </ul>
        </div>
        
        <div class="effect-category adverse">
          <h4>‚ùÅEAdverse Effects</h4>
          <ul>
            <li>Hypertension and cardiovascular strain</li>
            <li>Palpitations and irregular heartbeat</li>
            <li>Anxiety, jitteriness, and restlessness</li>
            <li>Insomnia and sleep disturbances</li>
            <li>Headache and dizziness</li>
            <li>Nausea and gastrointestinal upset</li>
            <li>Excessive sweating</li>
            <li>Tremor and muscle tension</li>
          </ul>
        </div>
      </div>

      <div class="unique-characteristics">
        <h4>‚ö° Ephedrine's Unique Profile</h4>
        <ul>
          <li><strong>Dual Œ±/Œ≤ activity:</strong> Both alpha and beta adrenergic receptor agonist</li>
          <li><strong>Peripheral focus:</strong> More peripheral than central nervous system effects</li>
          <li><strong>Long duration:</strong> 4-6 hour duration, longer than most stimulants</li>
          <li><strong>Bronchodilator:</strong> Specific therapeutic benefit for asthma</li>
          <li><strong>Thermogenic:</strong> Increases metabolic rate and fat burning</li>
          <li><strong>Natural origin:</strong> Plant-derived vs. synthetic stimulants</li>
          <li><strong>Less euphoric:</strong> Limited recreational appeal due to side effect profile</li>
        </ul>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>Ephedrine is a mixed-acting sympathomimetic that works through both direct and indirect mechanisms. It directly stimulates Œ±‚ÇÅE Œ±‚ÇÅE Œ≤‚ÇÅE and Œ≤‚ÇÅEadrenergic receptors while also promoting norepinephrine release from presynaptic terminals. This dual action creates sustained cardiovascular and bronchodilator effects. Unlike amphetamines, ephedrine has minimal direct central nervous system penetration.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor-name"><strong>Œ±‚ÇÅEadrenergic receptor</strong></span>
            <span class="affinity">Moderate agonist</span>
            <span class="function">Vasoconstriction, increased blood pressure, nasal decongestion</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Œ≤‚ÇÅEadrenergic receptor</strong></span>
            <span class="affinity">Moderate agonist</span>
            <span class="function">Increased heart rate, cardiac contractility</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Œ≤‚ÇÅEadrenergic receptor</strong></span>
            <span class="affinity">Moderate agonist</span>
            <span class="function">Bronchodilation, thermogenesis, lipolysis</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Œ±‚ÇÅEadrenergic receptor</strong></span>
            <span class="affinity">Weak agonist</span>
            <span class="function">Presynaptic modulation, some CNS effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Norepinephrine transporter</strong></span>
            <span class="affinity">Weak inhibition</span>
            <span class="function">Indirect sympathomimetic effects</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Absorption:</strong> Well absorbed orally, peak plasma 1-3 hours</p>
          <p><strong>Distribution:</strong> Limited CNS penetration, predominantly peripheral</p>
          <p><strong>Metabolism:</strong> Hepatic N-demethylation, oxidative deamination</p>
          <p><strong>Elimination:</strong> Primarily renal excretion (60-77% unchanged)</p>
          <p><strong>Half-life:</strong> 3-6 hours (dose and pH dependent)</p>
          <p><strong>pH sensitivity:</strong> Acidic urine increases elimination</p>
        </div>

        <h4>Stereochemistry & Activity</h4>
        <div class="stereochemistry-info">
          <p><strong>(-)-Ephedrine:</strong> Natural form, more potent Œ±-activity</p>
          <p><strong>(+)-Ephedrine:</strong> Synthetic form, more potent Œ≤-activity</p>
          <p><strong>Pseudoephedrine:</strong> Diastereomer, primarily nasal decongestant</p>
          <p><strong>Clinical preference:</strong> (-)-Ephedrine for systemic effects</p>
        </div>

        <h4>Tolerance & Dependence</h4>
        <ul>
          <li><strong>Tolerance development:</strong> Occurs with repeated use, especially cardiovascular effects</li>
          <li><strong>Tachyphylaxis:</strong> Rapid tolerance to some effects within hours</li>
          <li><strong>Physical dependence:</strong> Minimal compared to other stimulants</li>
          <li><strong>Psychological dependence:</strong> Low potential due to limited euphoric effects</li>
          <li><strong>Withdrawal:</strong> Mild rebound fatigue and drowsiness</li>
          <li><strong>Cross-tolerance:</strong> Partial with other sympathomimetics</li>
        </ul>

        <h4>Unique Pharmacological Features</h4>
        <ul>
          <li><strong>Mixed mechanism:</strong> Both direct receptor agonism and indirect neurotransmitter release</li>
          <li><strong>Peripheral selectivity:</strong> Limited blood-brain barrier penetration</li>
          <li><strong>Longer duration:</strong> Sustained effects compared to epinephrine</li>
          <li><strong>pH-dependent excretion:</strong> Elimination varies with urine pH</li>
          <li><strong>Natural sympathomimetic:</strong> Plant-derived adrenergic agonist</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†ÔøΩEÔøΩESafety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Critical Safety Warnings</h4>
          <ul>
            <li><strong>Cardiovascular risks:</strong> Hypertension, arrhythmias, heart attack, stroke</li>
            <li><strong>Hyperthermia:</strong> Dangerous overheating, especially with exercise</li>
            <li><strong>Drug interactions:</strong> Dangerous with MAOIs, antidepressants</li>
            <li><strong>Medical conditions:</strong> Contraindicated in many cardiovascular conditions</li>
            <li><strong>Overdose risk:</strong> Narrow therapeutic window</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°ÔøΩEÔøΩEEssential Precautions</h4>
          <ul>
            <li><strong>Medical consultation:</strong> Discuss with healthcare provider before use</li>
            <li><strong>Blood pressure monitoring:</strong> Regular checks during use</li>
            <li><strong>Hydration:</strong> Maintain adequate fluid intake</li>
            <li><strong>Temperature awareness:</strong> Avoid overheating, especially during exercise</li>
            <li><strong>Dose limits:</strong> Never exceed recommended pharmaceutical dosing</li>
            <li><strong>Time restrictions:</strong> Avoid late-day dosing to prevent insomnia</li>
          </ul>
        </div>
      </div>

      <div class="medical-supervision">
        <h4>üè• Medical Supervision Requirements</h4>
        <ul>
          <li><strong>Initial assessment:</strong> Cardiovascular examination before use</li>
          <li><strong>Blood pressure monitoring:</strong> Regular checks during treatment</li>
          <li><strong>ECG monitoring:</strong> For patients with cardiac risk factors</li>
          <li><strong>Periodic evaluation:</strong> Reassess need for continued therapy</li>
          <li><strong>Emergency signs:</strong> Chest pain, severe headache, difficulty breathing</li>
        </ul>
      </div>

      <div class="contraindications">
        <h4>üö´ Absolute Contraindications</h4>
        <p><strong>Do not use if you have:</strong> Severe hypertension, coronary artery disease, arrhythmias, hyperthyroidism, pheochromocytoma, narrow-angle glaucoma, or are taking MAOIs. Pregnancy and breastfeeding are also contraindications for non-medical use.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏ÅEDrug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ Extremely Dangerous</h4>
          <ul>
            <li><strong>MAOIs:</strong> Hypertensive crisis, potentially fatal</li>
            <li><strong>Tricyclic antidepressants:</strong> Severe hypertension</li>
            <li><strong>Linezolid:</strong> MAOI activity, hypertensive crisis risk</li>
            <li><strong>Ergot alkaloids:</strong> Severe vasoconstriction</li>
            <li><strong>General anesthetics:</strong> Cardiac arrhythmias during surgery</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° High Risk</h4>
          <ul>
            <li><strong>Beta-blockers:</strong> Unopposed alpha stimulation, hypertension</li>
            <li><strong>Digoxin:</strong> Increased risk of cardiac arrhythmias</li>
            <li><strong>Theophylline:</strong> Enhanced CNS and cardiac stimulation</li>
            <li><strong>Other stimulants:</strong> Additive cardiovascular effects</li>
            <li><strong>Antihypertensives:</strong> Antagonistic effects</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Use Caution</h4>
          <ul>
            <li><strong>Caffeine:</strong> Synergistic stimulant effects</li>
            <li><strong>Aspirin:</strong> May increase ephedrine absorption</li>
            <li><strong>Urinary acidifiers:</strong> Increase ephedrine elimination</li>
            <li><strong>Diabetes medications:</strong> May affect blood glucose</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏ÅELegal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>ÔøΩEÔøΩE United States</h4>
            <p><strong>Controlled precursor</strong> - Legal for medical use but heavily regulated. Combat Methamphetamine Epidemic Act requires ID, purchase limits, and record keeping.</p>
          </div>
          <div class="jurisdiction">
            <h4>ÔøΩEÔøΩE United Kingdom</h4>
            <p><strong>Pharmacy medicine</strong> - Available without prescription but behind pharmacy counter with quantity restrictions.</p>
          </div>
          <div class="jurisdiction">
            <h4>ÔøΩEÔøΩE Canada</h4>
            <p><strong>Controlled precursor</strong> - Regulated under Controlled Drugs and Substances Act with licensing requirements.</p>
          </div>
          <div class="jurisdiction">
            <h4>ÔøΩEÔøΩE Australia</h4>
            <p><strong>Schedule 3</strong> - Pharmacist only medicine with quantity restrictions and record keeping.</p>
          </div>
        </div>
        
        <div class="precursor-laws">
          <h4>‚öñÔ∏ÅEMethamphetamine Precursor Restrictions</h4>
          <ul>
            <li><strong>Purchase limits:</strong> 3.6g per day, 9g per month (pseudoephedrine equivalent)</li>
            <li><strong>ID requirements:</strong> Government-issued photo ID mandatory</li>
            <li><strong>Electronic logging:</strong> National Precursor Log Exchange (NPLEx) system</li>
            <li><strong>Pharmacy restrictions:</strong> Behind-the-counter placement required</li>
            <li><strong>Penalties:</strong> Violations can result in federal charges</li>
          </ul>
        </div>
        
        <div class="sports-doping">
          <h4>üèÉ‚Äç‚ôÇÔøΩEÔøΩESports & Competition Status</h4>
          <p><strong>WADA prohibited:</strong> Ephedrine is banned in competition above 10 Œºg/mL urine concentration. Many sports organizations prohibit its use due to performance-enhancing effects.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Culture</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">2700 BCE</span>
          <p>Ma Huang first documented in Chinese medicine by Emperor Shen Nung</p>
        </div>
        <div class="history-event">
          <span class="year">1885</span>
          <p>Ephedrine first isolated from Ephedra vulgaris by Japanese chemist Nagayoshi Nagai</p>
        </div>
        <div class="history-event">
          <span class="year">1920s</span>
          <p>Introduced to Western medicine by K.K. Chen and Carl Schmidt</p>
        </div>
        <div class="history-event">
          <span class="year">1930s-50s</span>
          <p>Becomes standard treatment for asthma and nasal congestion</p>
        </div>
        <div class="history-event">
          <span class="year">1990s</span>
          <p>Popular in dietary supplements and weight loss products</p>
        </div>
        <div class="history-event">
          <span class="year">2004</span>
          <p>FDA bans ephedra dietary supplements due to cardiovascular deaths</p>
        </div>
        <div class="history-event">
          <span class="year">2005</span>
          <p>Combat Methamphetamine Epidemic Act restricts ephedrine sales</p>
        </div>
      </div>

      <div class="traditional-medicine">
        <h4>üèõÔøΩEÔøΩETraditional Chinese Medicine</h4>
        <p>Ma Huang (Ephedra sinica) has been used in Traditional Chinese Medicine for over 4,000 years, primarily for treating asthma, nasal congestion, and arthritis. In TCM theory, it "releases the exterior" and "disperses cold," making it valuable for treating wind-cold patterns. It was traditionally combined with other herbs to moderate its harsh effects and enhance therapeutic benefits.</p>
      </div>

      <div class="modern-restrictions">
        <h4>‚öñÔ∏ÅEThe Rise and Fall of Ephedra Supplements</h4>
        <p>In the 1990s, ephedra-containing dietary supplements became extremely popular for weight loss and athletic performance enhancement. However, reports of heart attacks, strokes, and deaths led to increased scrutiny. High-profile cases, including the death of baseball player Steve Bechler, prompted the FDA to ban ephedra in dietary supplements in 2004, marking one of the first major supplement bans in U.S. history.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Hypotension Treatment</h4>
          <p>Research into ephedrine's use in treating hypotension during spinal anesthesia and other medical procedures, particularly its rapid onset and reliability compared to newer agents.</p>
        </div>
        
        <div class="research-item">
          <h4>Metabolic Studies</h4>
          <p>Investigation of ephedrine's thermogenic and lipolytic effects, understanding its role in energy metabolism and potential applications in metabolic disorders.</p>
        </div>
        
        <div class="research-item">
          <h4>Respiratory Medicine</h4>
          <p>Continued research into ephedrine's bronchodilator properties and its place in modern asthma therapy, particularly in resource-limited settings.</p>
        </div>
        
        <div class="research-item">
          <h4>Pharmacogenomics</h4>
          <p>Studies on individual variations in ephedrine response, including genetic factors affecting metabolism and receptor sensitivity.</p>
        </div>
        
        <div class="research-item">
          <h4>Traditional Medicine Validation</h4>
          <p>Modern scientific validation of traditional ephedra preparations and their therapeutic effects, bridging ancient knowledge with contemporary medicine.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Resources & Safety Information</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Medical Information</h4>
        <ul>
          <li><strong>FDA Drug Information:</strong> Official prescribing information and safety alerts</li>
          <li><strong>Poison Control:</strong> 1-800-222-1222 for overdose emergencies</li>
          <li><strong>Professional databases:</strong> Lexicomp, Micromedex for drug interactions</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Legal Information</h4>
        <ul>
          <li><strong>DEA:</strong> Combat Methamphetamine Epidemic Act compliance</li>
          <li><strong>NPLEx system:</strong> National precursor monitoring database</li>
          <li><strong>State regulations:</strong> Additional state-specific restrictions</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Traditional Medicine</h4>
        <ul>
          <li><strong>TCM resources:</strong> Traditional Chinese Medicine references</li>
          <li><strong>Herbalism databases:</strong> Modern herbal medicine information</li>
          <li><strong>Ethnobotany:</strong> Traditional uses across cultures</li>
        </ul>
      </div>
    </div>
  </div>

  <div class="ephedrine-warning-section">
    <h3>üö® Important Medical Disclaimer</h3>
    <div class="warning-content">
      <p><strong>Ephedrine is a potent cardiovascular stimulant:</strong> Its therapeutic use requires careful medical supervision due to significant risks of hypertension, cardiac arrhythmias, and other serious adverse effects.</p>
      
      <p><strong>Not for recreational use:</strong> Ephedrine has a poor risk-to-benefit ratio for non-medical purposes. The cardiovascular risks far outweigh any potential recreational benefits.</p>
      
      <p><strong>Legal compliance required:</strong> Purchase and possession are heavily regulated. Violations of precursor laws can result in serious federal charges.</p>
      
      <p><strong>Medical supervision essential:</strong> Anyone considering ephedrine use should consult with a healthcare provider to assess cardiovascular risk factors and determine appropriate dosing and monitoring.</p>
      
      <p><strong>Emergency signs:</strong> Seek immediate medical attention for chest pain, severe headache, difficulty breathing, rapid or irregular heartbeat, or signs of stroke.</p>
    </div>
  </div>

</div>


    </main>
     <div class="footer-divider"></div>
<footer class="site-footer">
  
</footer>




<footer class="site-footer">
  
  </svg>
    <img src="/Dyo-s-Dubious-Domain/assets/logo.svg" alt="My Logo" class="logo">
     <p>¬© 2025 Uwaniumnya. Highly Illegal.</p>
  </footer>

  

    <!-- Search Scripts -->
    <script src="/Dyo-s-Dubious-Domain/js/lunr.min.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/search.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/substance-integration.js"></script>
    
    <!-- Only load profile.js on profile page -->
    
    
    <!-- Only load interaction-checker.js on interaction checker page -->
    
</body>
</html>